InvestorsHub Logo
Followers 481
Posts 60449
Boards Moderated 18
Alias Born 09/20/2001

Re: None

Thursday, 12/01/2016 5:47:30 PM

Thursday, December 01, 2016 5:47:30 PM

Post# of 21524
Well apparently there's a ton of preferred out there too - From the reverse merger announcement, starting to sound like an OPM scheme (Other People's Money):


At the closing of the reverse merger, each of the 19,000,000 shares of Neurotrope's common stock outstanding immediately prior to the closing of the merger was converted into one share of the Company's common stock, and each of the 21,920,000 shares of Neurotrope's Series A convertible preferred stock outstanding immediately prior to the closing of the merger was converted into one share of the Company's Series A convertible preferred stock. After giving effect to the closings of the reverse merger and the private placement, there are 21,700,000 shares of Company common stock and 21,920,000 shares of Company Series A convertible preferred stock outstanding.

....


In addition, the Company's Board of Directors adopted, and its stockholders have approved, a 2013 Equity Incentive Plan, which provides for the issuance of incentive awards of up to 7,000,000 shares of the Company's common stock to officers, key employees, consultants and directors.



http://www.neurotropebioscience.com/Welcome_to_Neurotrope_BioScience/Reverse_IPO_Release.html



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SNPX News